Improving the diagnosis of Alzheimer’s disease thanks to European research collaboration

Dates: 
05-12-2017
Location: 
Brussels, Belgium

5 December 2017
12:30 – 14:00
European Parliament, Room JAN4Q2

60 Rue Wiertz, 1047 Brussels, Belgium

 

Agenda

Welcome

Heinz K. Becker, MEP, Member of the European Alzheimer’s Alliance

 

Diagnosing Alzheimer’s disease and Alzheimer’s dementia: A paradigm shift thanks to biomarkers

Prof. Philip Scheltens, VUMC Amsterdam, Netherlands

 

Promoting the timely diagnosis of neurocognitive disorders: Lessons from the European Joint Action on Dementia

Prof. Pierre Krolak-Salmon, Institut du Vieillissement, Lyon, France

 

Supporting clinicians in making a diagnosis: The PredictND clinical decision support tool

Dr Jyrki Lötjönen, Combinostics, Helsinki, Finland

 

The AD portfolio of the Innovative Medicines Initiative and its AMYPAD and MOPEAD projects

Dr Elisabetta Vaudano, Innovative Medicines Initiative

 

Closing remarks

Olga Sehnalová, MEP, Member of the European Alzheimer’s Alliance

 

For more information, please contact: info@alzheimer-europe.org